Stay updated with breaking news from Immune Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Initial Results From A Phase 1 Study of CFT8634, A Novel Bifunctional Degradation Activating Compound of BRD9, in Synovial Sarcoma and SMARCB1-Null Tumors ...
/PRNewswire/ -- The Southern California Biomedical Council (SoCalBio) -- the trade association for bioscience and digital health professionals across Greater...
Sensei Biotherapeutics Appoints William Ringo, MBA, as Chair of Board of Directors - Brings decades of both board and management life sciences experience ... | March 9, 2022